Research progress in ultrasound-guided targeted puncture biopsy of prostate cancer
Zhou Shan1, Chen Jin1, Niu Xiaobing2,*
1Department of Ultrasonagraphy,the Affiliated Huaian No.1, People's Hospital of Nanjing Medical University, Huaian 223300,China; 2Department of Urology, the Affiliated Huaian No.1, People's Hospital of Nanjing Medical University, Huaian 223300,China
Abstract：Currently, transrectal ultrasound-guided systematic biopsy of the prostate remains the gold standard for the diagnosis of prostate cancer. Compared with systematic biopsy, targeted prostate biopsy can improve the positive rate of prostate cancer diagnosis, reduce the number of puncture stitches and reduce complications. With the development of ultrasound technology, colour Doppler ultrasound, energy Doppler ultrasound, contrast-enhanced ultrasound and ultrasound elastography have been commonly used in the diagnosis of prostate cancer, and multiparametric ultrasound is playing an increasingly important role in targeted prostate biopsy.
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Canser J Clin, 2021,71(3): 209-249. [2] 顾秀瑛, 郑荣寿, 张思维, 等. 2000-2014年中国肿瘤登记地区前列腺癌发病趋势及年龄变化分析[J]. 中华预防医学杂志, 2018,52(6): 586-592. [3] Gandaglia G, Albers P, Abrahamsson PA, et al. Structured population-based prostate-specifc antigen screening for prostate cancer: the European Association of Urology position in 2019[J]. Eur Urol, 2019,76(2): 142-150. [4] Loeb S, Bjurlin MA, Nicholson J, et al. Overdiagnosis and overtreatment of prostate cancer[J]. Eur Urol ,2014, 65(6): 1046-1055. [5] Correas JM, Halpern EJ, Barr RG, et al. Advanced ultrasound in the diagnosis of prostate cancer[J]. World J Urol, 2021, 39: 661-676. [6] Correas JM, Tissier AM, Khairoune A, et al. Prostate cancer: diagnostic performance of real-time shear-wave elastography[J]. Radiology, 2015, 275(1): 280. [7] 李盈盈, 张明博, 吴凡,等. 经直肠多模态超声与多模态MRI检查对前列腺癌诊断价值的对照研究[J]. 中华泌尿外科杂志, 2020, 41(1): 7. [8] Dias AB, O'Brien C, Correas JM, et al. Multiparametric ultrasound and micro-ultrasound in prostate cancer: a comprehensive review[J]. Br J Radiol, 2022, 95(1131): 20210633. [9] Tschirdewahn S, Wiesenfarth M, Bonekamp D, et al. Detection of significant prostate cancer using target saturation in transperineal MRI/ TRUS-fusion biopsy[J]. Eur Urol Focus, 2021 ,7(6): 1300-1307. [10] Zhu Y, Chen Y, Jiang J, et al. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients[J]. World Journal of Urology, 2019. [11] Lughezzani G, Saita A, Lazzeri M, et al. Comparison of the diagnostic accuracy of micro-ultrasound and magnetic resonance imaging/ultrasound fusion targeted biopsies for the diagnosis of clinically signifcant prostate cancer[J]. Eur Urol Oncol, 2019,2(3): 329-332. [12] Ghai S, Eure G, Fradet V, et al. Assessing cancer risk on novel 29 MHz microultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identifcation[J]. J Urol ,2016, 196(2): 562-569. [13] Pavlovich CP, Hyndman ME, Eure G, et al. A multi‐institutional randomized controlled trial comparing first‐generation transrectal high‐resolution micro‐ultrasound with conventional frequency transrectal ultrasound for prostate biopsy[J]. BJUI Compass, 2020, 2(2): 126-133. [14] Linden, RA, HalpernE J. Advances in transrectal ultrasound imaging of the prostate[J]. Semin Ultrasound CT MR, 2007, 28(4): 249-257. [15] Zhu YC, Shan J, Zhang Y, et al. Prostate cancer vascularity: superb microvascular imaging ultrasonography with histopathology correlation[J]. Med Sci Monit ,2019,25: 8571-8578. [16] Schiffmann J, Mehring G, Tennstedt P, et al. True targeting-derived prostate biopsy: HistoScanningTM remained inadequate despite advanced technical efforts[J]. World JUrol, 2016, 34(4): 495-500. [17] Barr RG, Cosgrove D, Brock M, et al. WFUMB guidelines and recommendations on the clinical use of ultrasound elastography: part 5. prostate[J]. Ultrasound Med Biol, 2017, 43(1): 27-48. [18] Ferrari FS, Scorzelli A, Megliola A, et al. Real-time elastography in the diagnosis of prostate tumor[J]. J Ultrasound ,2009, 12(1): 22-31. [19] Brock M, von Bodman C, Palisaar RJ, et al. The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 patients[J]. J Urol, 2012, 187(6): 2039-2043. [20] Halpern EJ, Gomella LG, Forsberg F, et al. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: arandomized, double-blind trial of dutasteride pretreatment[J]. J Urol, 2012, 188(5): 1739-1745. [21] Li YM, Tang J, Fei X, et al. Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: a meta-analysis[J]. Acad Radiol, 2013, 20(2): 156-164.
